These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12493403)

  • 1. Emerging challenges in transplantation in developing countries.
    Rizvi SA; Naqvi SA; Hussain Z; Hashmi A; Akhtar F; Hussain M; Ahmed E; Zafar MN; Muzaffar R; Hafiz S
    Transplant Proc; 2002 Dec; 34(8):3146-9. PubMed ID: 12493403
    [No Abstract]   [Full Text] [Related]  

  • 2. Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survival.
    Savoldi S; Maiorca R; Maderna M; Chiappini R; Corbetta G
    Transplant Proc; 1997; 29(1-2):288-9. PubMed ID: 9122999
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.
    Okazaki H; Sato T; Miura S; Amada N
    Transplant Proc; 1997; 29(1-2):200-2. PubMed ID: 9122962
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
    Jonker M; van den Hout Y; Neuhaus P; Ringers J; Kuhn EM; Bruijn JA; Schuurman HJ; Noort R; Bontrop RE; Claas FH; van Rood JJ
    Transplant Proc; 1998 Aug; 30(5):2451-3. PubMed ID: 9723534
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation.
    Morrissey PE; Gohh RY; Monaco AP
    Transplant Proc; 2002 Aug; 34(5):1640-1. PubMed ID: 12176517
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine Neoral profiling in Japanese renal transplant recipients.
    Aikawa A; Arai K; Tajima E; Kawamura T; Ogiwara H; Sakai K; Mizuiri S; Ohara T; Hasegawa A; Kosugi T; Kusano A; Matsuo K; Obayashi M; Kurokawa M
    Transplant Proc; 2001; 33(7-8):3142-5. PubMed ID: 11750350
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantation.
    Mathew TH; McDonald SP; Russ GR
    Transplant Proc; 2001; 33(7-8):3400-2. PubMed ID: 11750455
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
    Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
    Gracida C; Melchor JL
    Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S; Aikawa M; Dobashi Y; Kuzuhara K; Yanagisawa T; Ootubo O; Mimura N
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract]   [Full Text] [Related]  

  • 12. Early cyclosporine concentration as predictor of graft survival in cadaveric renal transplantation.
    Salmela K; Kyllönen L
    Transplant Proc; 2001 Jun; 33(4):2441-3. PubMed ID: 11406202
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression.
    Tanabe K; Ishida H; Tokumoto T; Shimmura H; Toda F; Omoto K; Makiyama K; Yagisawa T; Fuchinoue S; Teraoka S; Toma H
    Transplant Proc; 2002 Aug; 34(5):1668-70. PubMed ID: 12176528
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression strategies in developing countries.
    Naqvi SA
    Transplant Proc; 2002 Sep; 34(6):2083-4. PubMed ID: 12270322
    [No Abstract]   [Full Text] [Related]  

  • 16. Trough cyclosporine concentration variability.
    Savoldi S; Maiorca R; Chiappini R; Scolari F; Sandrini S
    Transplant Proc; 1998 Aug; 30(5):1642-4. PubMed ID: 9723225
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoral C2 monitoring in solid organ transplantation.
    Levy GA
    Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506 in cadaveric kidney transplantation from non-heart-beating donors.
    Hattori R; Ohshima S; Ono Y; Fujita T; Kinukawa T; Matsuura O
    Transplant Proc; 1998 Nov; 30(7):3801-3. PubMed ID: 9838666
    [No Abstract]   [Full Text] [Related]  

  • 20. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
    Mulloy LL; Wright F; Hall ML; Moore M
    Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.